Study on Clinical Features and Outcomes of Breast Sarcoma
Key facts
- Where
- Ancona, Aviano, Bologna, Candiolo, Florence, Milan, Palermo, Prato, Roma, Rozzano, Torino, and Turin, ItalySee the 14 sites
Where in Italy
- A.O Ospedali Riuniti Marche NordAncona, ItalyNot yet recruiting
- Centro di Riferimento Oncologico - Unit of Medical OncologyAviano, ItalyNot yet recruiting
- Azienda Ospedaliera S.Orsola MalpighiBologna, ItalyNot yet recruiting
- Fondazione del Piemonte per l'Oncologia IRCC CandioloCandiolo, ItalyTaking people
- Azienda Ospedaliera Universitaria CareggiFlorence, ItalyNot yet recruiting
- Fondazione IRCCS INT - MilanoMilan, ItalyNot yet recruiting
- Istituto Europeo di OncologiaMilan, ItalyNot yet recruiting
- Azienda Ospedaliera Universitaria Paolo GiacconePalermo, ItalyNot yet recruiting
- Ospedale Misericordia e DolcePrato, ItalyNot yet recruiting
- Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology IRoma, ItalyNot yet recruiting
- Policlinico Universitario Campus BiomedicoRoma, ItalyNot yet recruiting
- Istituto Clinico HumanitasRozzano, ItalyNot yet recruiting
- ASL Città di Torino (Dipartimento di Oncologia)Torino, ItalyNot yet recruiting
- Ospedale Umberto ITurin, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Italian Sarcoma Group
- Trial code
- NCT04749446
- Record updated
- 2 January 2026
- Original description
This is multi-institutional retrospective study in order to identify the most relevant clinical characteristics, treatment strategies, to explore the impact on principal clinical outcomes and finally, to suggest some principles for management and treatment of breast sarcomas.Read full original descriptionShow less
Breast Sarcomas: A Retrospective Analysis of Clinical Features and Outcomes
This is multi-institutional retrospective study in order to identify the most relevant clinical characteristics, treatment strategies, to explore the impact on principal clinical outcomes and finally, to suggest some principles for management and treatment of breast sarcomas.
The study will collect data about patients affected by breast sarcoma referred to participating Institutions between January 2000 and June 2020
Inclusion: >18 years at diagnosis; primary or secondary breast sarcoma; availability of medical data needed for the study (histopathological data, surgery, chemotherapy, including preceding chemotherapeutic regimens for secondary breast sarcomas, radiation therapy).
Exclusion: sarcoma metastases to the breast; chest wall sarcomas not arising in the mammary gland; cutaneous sarcomas.